| # | Title | Journal | Year | Citations |
|---|
| 1 | Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial | Lancet, The | 1999 | 1,493 |
| 2 | Tertiary lymphoid structures improve immunotherapy and survival in melanoma | Nature | 2020 | 1,209 |
| 3 | Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial | Lancet Oncology, The | 2015 | 661 |
| 4 | Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution | Cell Metabolism | 2016 | 572 |
| 5 | Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression | Nature Medicine | 2016 | 456 |
| 6 | Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration | Journal of Clinical Oncology | 2020 | 448 |
| 7 | MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer | JAMA - Journal of the American Medical Association | 2014 | 380 |
| 8 | Molecular Mechanisms Linking Exercise to Cancer Prevention and Treatment | Cell Metabolism | 2018 | 333 |
| 9 | Testicular cancer | Nature Reviews Disease Primers | 2018 | 299 |
| 10 | Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2015 | 291 |
| 11 | Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015 | Annals of Oncology | 2015 | 279 |
| 12 | The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise | Acta Oncológica | 2008 | 232 |
| 13 | ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up | Annals of Oncology | 2018 | 228 |
| 14 | Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial | Lancet, The | 2020 | 226 |
| 15 | The forefront of ovarian cancer therapy: update on PARP inhibitors | Annals of Oncology | 2020 | 191 |
| 16 | Direct Therapeutic Applications of Calcium Electroporation to Effectively Induce Tumor Necrosis | Cancer Research | 2012 | 177 |
| 17 | Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma | Annals of Oncology | 2019 | 170 |
| 18 | Oral clodronate in breast cancer patients with bone metastases: a randomized study | Journal of Internal Medicine | 1999 | 167 |
| 19 | Muscle dysfunction in cancer patients | Annals of Oncology | 2014 | 162 |
| 20 | A Nationwide Cohort Study of Stage I Seminoma Patients Followed on a Surveillance Program | European Urology | 2014 | 151 |
| 21 | Principles of adoptive T cell therapy in cancer | Seminars in Immunopathology | 2019 | 141 |
| 22 | Clinical advances and ongoing trials of mRNA vaccines for cancer treatment | Lancet Oncology, The | 2022 | 140 |
| 23 | The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial | Breast Cancer Research and Treatment | 2010 | 137 |
| 24 | Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies | Annals of Oncology | 2007 | 136 |
| 25 | Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer | Cancer Immunology, Immunotherapy | 2014 | 135 |
| 26 | Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients | Journal of Translational Medicine | 2012 | 134 |
| 27 | Management of cutaneous metastases using electrochemotherapy | Acta Oncológica | 2011 | 133 |
| 28 | MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma | Modern Pathology | 2012 | 133 |
| 29 | PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab | Annals of Oncology | 2012 | 122 |
| 30 | Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study | Annals of Oncology | 2014 | 122 |
| 31 | Evaluation of radiotherapy in high-risk breast cancer patients: Report from the Danish Breast Cancer Cooperative Group (DBCG 82) trial | International Journal of Radiation Oncology Biology Physics | 1990 | 120 |
| 32 | Patch‐based generation of a pseudo CT from conventional MRI sequences for MRI‐only radiotherapy of the brain | Medical Physics | 2015 | 119 |
| 33 | Histone deacetylase 1, 2, 6 and acetylated histone H4 in B‐ and T‐cell lymphomas | Histopathology | 2009 | 118 |
| 34 | Exercise-Induced Catecholamines Activate the Hippo Tumor Suppressor Pathway to Reduce Risks of Breast Cancer Development | Cancer Research | 2017 | 117 |
| 35 | Plasma YKL-40 levels in healthy subjects from the general population | Clinica Chimica Acta | 2011 | 115 |
| 36 | Electrochemotherapy for large cutaneous recurrence of breast cancer: A phase II clinical trial | Acta Oncológica | 2012 | 113 |
| 37 | KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in BRAF-mutant melanoma | | 2020 | 110 |
| 38 | Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T‐cell lymphoma | Histopathology | 2008 | 109 |
| 39 | Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial | Cancer Immunology, Immunotherapy | 2012 | 103 |
| 40 | Latest clinical evidence and further development of PARP inhibitors in ovarian cancer | Annals of Oncology | 2018 | 101 |
| 41 | Cryopreservation of ovarian tissue for fertility preservation: no evidence of malignant cell contamination in ovarian tissue from patients with breast cancer | Fertility and Sterility | 2011 | 100 |
| 42 | Antiemetics: an update and the MASCC guidelines applied in clinical practice | Nature Clinical Practice Oncology | 2008 | 96 |
| 43 | A voxel-based investigation for MRI-only radiotherapy of the brain using ultra short echo times | Physics in Medicine and Biology | 2014 | 89 |
| 44 | A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma | Nature Medicine | 2021 | 88 |
| 45 | Current trends in patient and public involvement in cancer research: A systematic review | Health Expectations | 2019 | 87 |
| 46 | The group matters: an explorative study of group cohesion and quality of life in cancer patients participating in physical exercise intervention during treatment | European Journal of Cancer Care | 2006 | 86 |
| 47 | Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers | Cancer Immunology, Immunotherapy | 2007 | 85 |
| 48 | Population-Based Study of Peritumoral Lymphovascular Invasion and Outcome Among Patients With Operable Breast Cancer | Journal of the National Cancer Institute | 2009 | 85 |
| 49 | Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer | Annals of Oncology | 2013 | 83 |
| 50 | Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants | Genetics in Medicine | 2020 | 82 |
